BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9282506)

  • 1. Seroprevalence of cytomegalovirus antibodies in patients attending STD and antenatal clinics.
    Ray K; Mahajan M
    J Commun Dis; 1997 Jun; 29(2):85-90. PubMed ID: 9282506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey.
    Uyar Y; Balci A; Akcali A; Cabar C
    New Microbiol; 2008 Oct; 31(4):451-5. PubMed ID: 19123299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
    Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
    Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High perinatal seroprevalence of cytomegalovirus in northern Taiwan.
    Chen MH; Chen PC; Jeng SF; Hsieh CJ; Su FC; Liao HF; Su YN; Lin SJ; Hsieh WS
    J Paediatr Child Health; 2008 Apr; 44(4):166-9. PubMed ID: 17854407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of CMV seroconversion in a Swiss pregnant women population.
    Maine GT; Stricker R; Stricker R
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):275-7. PubMed ID: 22541330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMV seroconversion in pregnants and the incidence of congenital CMV infection.
    Satilmiş A; Güra A; Ongun H; Mendilcioğlu I; Colak D; Oygür N
    Turk J Pediatr; 2007; 49(1):30-6. PubMed ID: 17479641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.
    Eskild A; Jenum PA; Bruu AL
    Acta Obstet Gynecol Scand; 2005 Nov; 84(11):1035-41. PubMed ID: 16232169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey.
    Ocak S; Zeteroglu S; Ozer C; Dolapcioglu K; Gungoren A
    Scand J Infect Dis; 2007; 39(3):231-4. PubMed ID: 17366053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seroepidemiological study on cytomegalovirus in women of child-bearing age with special reference to pregnancy and maternal-fetal transmission.
    Chakravarty A; Kashyap B; Rathi K
    Indian J Pathol Microbiol; 2005 Oct; 48(4):518-21. PubMed ID: 16366116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa.
    Bos P; Steele D; Alexander J
    Cent Afr J Med; 1995 Jan; 41(1):14-7. PubMed ID: 7767930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.
    Aljumaili ZK; Alsamarai AM; Najem WS
    J Infect Public Health; 2014; 7(4):277-88. PubMed ID: 24629348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytomegalovirus IgM amd IgG antibodies in the sera of patients with acute and chronic upper respiratory infections].
    Cengiz AT; Ataoğlu H; Kiyan M; Kiliç H
    Mikrobiyol Bul; 1990 Oct; 24(4):307-13. PubMed ID: 1962842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of cytomegalovirus (CMV) IgG and IgM in homosexuals and transsexuals using ELISA].
    Kiyan M; Cengiz AT; Kendi O; Tümer AR; Bilge Y; Uğurel MS
    Mikrobiyol Bul; 1993 Apr; 27(2):119-26. PubMed ID: 8388984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
    Jin Q; Su J; Wu S
    J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
    Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in a cohort of pregnant women.
    El Sanousi SM; Osman ZA; Mohmed AB; Al Awfi MS
    Am J Infect Control; 2016 Apr; 44(4):e41-3. PubMed ID: 26810886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of cytomegalovirus infections in Croatia.
    Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study.
    Erfanianahmadpoor M; Nasiri R; Vakili R; Hassannia T
    Saudi Med J; 2014 Apr; 35(4):360-4. PubMed ID: 24749132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
    Carlier P; Harika N; Bailly R; Vranken G
    J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.